Trulicity Injection 1.5 mg/0.5 ml contains Dulaglutide, a long-acting GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes mellitus. It is administered once weekly and is used along with diet and exercise to help manage blood glucose levels effectively.

This higher-strength formulation is typically used when additional glycemic control is needed, based on patient response and physician recommendation.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each prefilled pen contains:

• Dulaglutide 1.5 mg in 0.5 ml solution

Available as a single-dose subcutaneous injection.

Indications

Trulicity Injection is indicated for:

• Type 2 diabetes mellitus (monotherapy or combination therapy)
• Improvement of glycemic control in adults
• Reduction of risk of major cardiovascular events in patients with type 2 diabetes (as advised by physicians)

Mechanism of Action

Dulaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It helps control blood sugar by:

• Stimulating insulin secretion when glucose levels are high
• Reducing glucagon release from the pancreas
• Slowing gastric emptying
• Reducing appetite and food intake

These actions help lower blood glucose levels and may also support weight reduction in many patients.

Dosage and Administration

Trulicity Injection should be used exactly as prescribed by a healthcare professional.

General guidelines:

• Administered once weekly on the same day each week
• Injected subcutaneously in the abdomen, thigh, or upper arm
• Can be taken with or without food
• Rotate injection sites each time
• Do not mix with insulin in the same syringe

Dosage may be adjusted depending on blood sugar control and tolerance.

Benefits of Trulicity Injection

• Effective control of type 2 diabetes
• Once-weekly convenient dosing
• Helps reduce HbA1c levels
• May support weight loss
• Low risk of hypoglycemia when used alone
• May reduce cardiovascular risk in diabetic patients

Possible Side Effects

Some patients may experience:

• Nausea
• Vomiting
• Diarrhea
• Abdominal discomfort
• Reduced appetite
• Indigestion

Less common but serious side effects include:

• Pancreatitis
• Gallbladder disease
• Severe allergic reactions
• Kidney function changes (rare)

Precautions and Warnings

• Not indicated for type 1 diabetes or diabetic ketoacidosis
• Use cautiously in patients with history of pancreatitis
• Monitor blood glucose regularly
• May cause dehydration due to gastrointestinal effects
• Use during pregnancy only if clearly needed and prescribed
• Inform physician about all ongoing medications

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store in refrigerator (2°C to 8°C)
• Do not freeze
• Protect from light
• Do not shake the pen
• Keep out of reach of children

Conclusion

Trulicity Injection 1.5 mg/0.5 ml (Dulaglutide) is a once-weekly GLP-1 receptor agonist used for effective management of type 2 diabetes mellitus. It helps improve blood sugar control, supports weight management, and may reduce cardiovascular risks in selected patients. Proper use under medical supervision ensures safe and effective long-term diabetes control.